{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 12
    }
  },
  "results": [
    {
      "spl_product_data_elements": [
        "Esokalli Slimming microcrystalline patch Esokalli Slimming microcrystalline patch CELLULOSE, MICROCRYSTALLINE POLYVINYL ALCOHOL, UNSPECIFIED RETATRUTIDE RETATRUTIDE DIMETHICONE, UNSPECIFIED SUCROSE"
      ],
      "components": [
        "Active ingredient (in each patch) Retatrutide 1.6 mg ……………………………. Weight management / blood sugar control"
      ],
      "purpose": [
        "Purpose Weight loss aid Improves blood sugar control (when used with diet and exercise)"
      ],
      "indications_and_usage": [
        "Uses To support weight management To improve glycemic control in adults with type 2 diabetes mellitus Provides long-acting sustained-release delivery via soluble microneedle patch"
      ],
      "warnings": [
        "Warnings For external use only"
      ],
      "dosage_and_administration": [
        "Dosage and administration For external use only."
      ],
      "do_not_use": [
        "Do not use if you have type 1 diabetes need treatment for diabetic ketoacidosis are pregnant or breastfeeding are under 18 years of age"
      ],
      "when_using": [
        "When using this product monitor blood glucose regularly possible side effects include: hypoglycemia nausea, vomiting, or diarrhea acute pancreatitis complications of diabetic retinopathy increased heart rate hypersensitivity or allergic reactions"
      ],
      "stop_use": [
        "Stop use and ask a doctor if • you develop severe abdominal pain (possible acute pancreatitis) • symptoms of hypersensitivity occur (rash, swelling, difficulty breathing) • persistent gastrointestinal problems occur"
      ],
      "keep_out_of_reach_of_children": [
        "Keep out of reach of children. In case of accidental ingestion, get medical help or contact a Poison Control Center right away."
      ],
      "inactive_ingredient": [
        "Inactive ingredients Microcrystalline matrix, soluble microneedle polymer blend, stabilizers, adhesive layer."
      ],
      "package_label_principal_display_panel": [
        "PRINCIPAL DISPLAY PANEL 1 2 3 4"
      ],
      "set_id": "3d18a8a9-68a4-1406-e063-6294a90a225c",
      "id": "3d18a8a9-68a5-1406-e063-6294a90a225c",
      "effective_time": "20250824",
      "version": "1",
      "openfda": {}
    }
  ]
}